Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Determine which no fee travel card is better suited for you. Make the right choice for your travel goals and preferences.
22,207 articlesA late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
SK Hynix moves to list American Depository Receipts on Nasdaq, broadening U.S. investor access. The plan comes as AI-...
A data-driven model now sees roughly 36% upside for Qualcomm stock within a year, even after a choppy period around i...
Tate Ferdinand makes a candid return to Kate Ferdinand’s Blended podcast to talk about life inside a blended family. ...
In uncertain times, reliable income matters. Learn why wide-moat dividend stocks hold steady, using Coca-Cola and Joh...
The MORT ETF offers a double-digit yield, but its payout hinges on the health of its mortgage REIT holdings. This art...
Three Buy-rated names are drawing fresh attention in June as Wall Street echoes a defensive, cash-flow bias. AutoZone...
A TD Cowen analyst floated SpaceX purchasing T-Mobile, turning heads in investing circles as markets weigh strategic ...
Snap co-founder Evan Spiegel and Miranda Kerr are funding a California medical debt relief program, potentially wipin...
OpenAI's planned IPO faces a timing change that could redefine AI stock bets. The shift underscores a tougher funding...
Markets confront a rebalanced risk outlook as Iran signals it may push for nuclear concessions to survive. Investors ...
A flurry of news sent Kymera Therapeutics stock popping this week. From trial milestones to new price targets and ins...